Brief Report: A Bioassay to Identify Primary Human Prostate Cancer Repopulating Cells

Abstract

Cancer cells are heterogeneous in both their phenotypes and ability to promote tumor growth and spread. Xenografting is used to identify the most highly capable cells of regenerating tumors, referred to as cancer repopulating cells. Because prostate cancers (PCa's) rarely grow as xenografts, indentifying PCa repopulating cells has not been possible. Here, we report improved methods to xenograft localized primary PCa tissues using chimeric grafts with neonatal mouse mesenchyme. Xenograft survival of tumor tissue was significantly increased by neonatal mesenchyme (six of six patients, 66% of grafts, versus four of six patients, 41% of grafts) and doubled the proliferation index of xenografted cancer cells. When applied to isolated PCa cells, neonatal mesenchyme effectively reconstituted PCa's and increased xenograft survival (four of nine patients; 32% of grafts with mesenchyme and 0% without), and supported active cancer cell proliferation. Using this assay, we showed that unfractionated α2β1integrinhi and α2β1integrinlo cells from primary localized PCa's demonstrated tumor formation at comparable rates, similar to previous reports using metastatic specimens. Thus, this new protocol efficiently established tumors and enabled proliferative expansion of both intact tumor tissue and fractionated cancer cells, providing a bioassay to identify and therapeutically target PCa repopulating cells. STEM CELLS 2011;29:1310–1314

Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

“…Grafts were implanted under the kidney capsule of NOD/SCID g (NSG) mice and analysed using immunohistochemistry (Table 1). This technique has been used extensively and has been described by this group [17][18][19]. Uropathologists (D.C. and J.P.)…”

Breaking through a roadblock in prostate cancer research: An update on human model systems

“…For example, data from Loda and coworkers suggested that if survival is specifically considered as the presence of malignant foci in grafts at the time of harvest, and not merely the ability to retrieve graft tissue, then overall survival rates are actually significantly lower than first reported [31]. We, and others, specifically reported the survival of malignant foci, rather than survival of human tissue regardless of the pathology detected, to be ∼50% [31,34]. This could be due to the loss of malignant foci in the graft in the host milieu, through mechanisms such as apoptosis, or failure to survive or grow in the first place.…”

Growth, Clonability, and Radiation Resistance of Esophageal Carcinoma-derived Stem-like Cells

“…Soft agar cloning experiments are typically used to detect the growth of non-adherent of tumor cells (Bentivegna et al, 2010;Toivanen et al, 2011). Not all tumor cells have the ability to form colonies in soft agar; colony formation of tumor cells is positively correlated with their tumorigenic ability (Freedman et al, 1974).…”